OTC:RVPH | Cash Flow Statement | REVIVA PHARMACEUTICALS HOLDINGS, INC.

Complete source-backed cash-flow history.

Available history
2018-05-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.45M
2026-03-31-$3.2M-$3.8M$11.55M
2025-12-31-$3.37M-$5.8M$7.05M
2025-09-30-$4.01M
2025-06-30-$6.05M
2025-03-31-$6.43M-$8.19M$7,271.00
2024-12-31-$6.26M-$9.1M$17.02M
2024-09-30-$8.37M
2024-06-30-$7.86M
2024-03-31-$7.43M-$11.73M$332,000.00
2023-12-31-$9.36M-$8.88M$27.27M
2023-09-30-$11.35M
2023-06-30-$11.71M
2023-03-31-$6.85M-$7.95M$687,093.00
2022-12-31-$9.24M-$4.69M$18,563.00
2022-09-30-$3.52M
2022-06-30-$5.34M
2022-03-31-$7.37M-$6.27M$70.00
2021-12-31-$3.68M-$3.9M$98,481.00
2021-09-30-$2.28M
2021-06-30-$1.61M
2021-03-31-$949,300.00-$3.12M$0.00
2020-12-31-$1.52M-$2.94M$11.34M
2020-11-30-$348,207.00
2020-09-30-$659,088.00
2020-08-31-$516,032.00
2020-06-30-$851,433.00
2020-05-31-$155,766.00-$35,457.00$26.77M-$26.61M
2020-03-31-$748,962.00-$60,662.00$230,000.00
2020-02-29-$131,651.00-$247,850.00$5.7M-$5.52M
2019-11-30$136,808.00
2019-08-31$274,320.00
2019-05-31$338,426.00-$39,363.00$0.00$0.00
2019-02-28$306,562.00-$87,910.00$0.00$0.00
2018-11-30$263,223.00
2018-08-31$17,687.00
2018-05-31-$13,341.00$11,659.00$18,341.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$19.86M-$24.59M$25.56M
2024-12-31-$29.92M-$33.54M$23.65M
2023-12-31-$39.26M-$28.32M$33.17M
2022-12-31-$28.26M-$18.96M$7.79M
2021-12-31-$8.52M-$10.67M$31.6M
2021-12-13-$8.52M
2020-12-31-$3.78M-$4.07M$12.83M
2020-02-29$617,903.00-$426,591.00$5.7M-$5.52M
2019-12-31-$846,832.00-$218,444.00$100,000.00
2019-02-28$574,131.00-$220,869.00-$64.52M$65.05M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.